CoChat

The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with neuroprotection

Espada, Sandra, Rojo, Ana I., Salinas, Marta, Cuadrado, Antonio · 2009 · Journal of Neurochemistry
Cited by 62

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In this study, we provide evidence that the muscarinic M1 receptor targets NF‐E2‐related factor‐2 (Nrf2), a transcription factor that regulates the expression of genes containing antioxidant response elements (AREs) in their promoters and that collectively constitute the phase II antioxidant response. In hippocampal primary and cerebellar granule neuron cultures expressing endogenous M1 receptor, carbachol increased the levels of a prototypical phase II antioxidant enzyme, heme oxygenase‐1. Moreover, in a heterologous system, based on lentiviral expression of M1 receptor in PC12 pheochromocytoma cells, we found that M1 increased total and nuclear Nrf2 protein levels and heme oxygenase‐1 messenger RNA and protein levels. Luciferase reporter constructs for AREs and the use of two inhibitors of protein kinase C (PKC), chelerythrine and 2‐aminoethyl diphenylborinate, or transfection with relevant expression vectors allowed us to identify Gαq, phospholipase C‐β and the classical PKC‐γ isoenzyme, as responsible for the regulation of Nrf2. A PKC‐insensitive Nrf2S40A single‐point mutant partially channeled M1 signaling to AREs, therefore suggesting the participation of additional intermediates. Inhibition of glycogen synthase kinase‐3β (GSK‐3β) augmented M1‐dependent activation of AREs while a PKC‐insensitive mutant of GSK‐3β (GSK‐3β‐Δ9) blocked this effect and prevented M1‐induced accumulation of Nrf2 in the nucleus. Our results demonstrate a previously unidentified role of the Gαq/phospholipase C‐β/PKC/GSK‐3β axis in regulation of Nrf2 by M1. Such role provides additional conceptual support for the use of cholinemimetics in the treatment of pathologies that, like Alzheimer’s disease, require a reinforcement of the cell antioxidant capacity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2009.06208.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 62

Metadata

Authors
Espada, S., Rojo, A. I., Salinas, M., & Cuadrado, A.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2009-07-13
Volume
110
Issue
3
Pages
1107-1119
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2025330029
Cited by
62
References
3
FWCI
1.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with neuroprotection. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.06208.x
The paper
Espada, S., Rojo, A. I., Salinas, M., & Cuadrado, A. (2009). The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with neuroprotection. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.06208.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.